Search

Your search keyword '"van Geuns, Robert-Jan"' showing total 1,636 results
Start Over Author "van Geuns, Robert-Jan"

Refine your results

more »

more »

more »

more »

more »
1,636 results on '"van Geuns, Robert-Jan"'

1. Impact of symptom duration and mechanical circulatory support on prognosis in cardiogenic shock complicating acute myocardial infarction

Author

Klein, Florien, Crooijmans, Caïa, Peters, Elma J., van ’t Veer, Marcel, Timmermans, Marijke J. C., Henriques, José P. S., Verouden, Niels J. W., Kraaijeveld, Adriaan O., Bunge, Jeroen J. H., Lipsic, Erik, Sjauw, Krischan D., van Geuns, Robert-Jan M., Dedic, Admir, Dubois, Eric A., Meuwissen, Martijn, Danse, Peter, Bleeker, Gabe, Montero-Cabezas, José M., Ferreira, Irlando A., Brouwer, Jan, Teeuwen, Koen, and Otterspoor, Luuk C.

Published
2024
Full Text
View/download PDF

2. Upper extremity versus lower extremity for secondary access during transcatheter aortic valve implantation: rationale and design of the randomised TAVI XS trial

Author

Rooijakkers, Maxim J. P., Versteeg, Geert A. A., Hemelrijk, Kimberley I., Aarts, Hugo M., Overduin, Daniël C., van Ginkel, Dirk-Jan, Vlaar, Pieter J., van Wely, Marleen H., van Nunen, Lokien X., van Geuns, Robert Jan, van Garsse, Leen A. F. M., Geuzebroek, Guillaume S. C., Verkroost, Michel W. A., Rodwell, Laura, Heijmen, Robin H., Tonino, Pim A. L., ten Berg, Jurrien M., Delewi, Ronak, and van Royen, Niels

Published
2024
Full Text
View/download PDF

4. Functional and morphological improvement of significant non-culprit coronary artery stenosis by LDL-C reduction with a PCSK9 antibody: Rationale and design of the randomized FITTER trial

Author

Mensink, Frans B., Los, Jonathan, Oemrawsingh, Rohit M., von Birgelen, Clemens, Ijsselmuiden, Alexander, Meuwissen, Martijn, Cheng, Jin M., van Wijk, Diederik F., Smits, Pieter C., Paradies, Valeria, van der Heijden, Dirk J., Rai, Himanshu, ten Cate, Tim JF., Camaro, Cyril, Damman, Peter, van Nunen, Lokien X., Dimitriu-Leen, Aukelien C., van Wely, Marleen H., Cetinyurek-Yavuz, Aysun, Byrne, Robert A., van Royen, Niels, and van Geuns, Robert-Jan M.

Published
2024
Full Text
View/download PDF

5. Sex differences in plaque characteristics of fractional flow reserve-negative non-culprit lesions after myocardial infarction

Author

Volleberg, Rick H.J.A., Mol, Jan-Quinten, Belkacemi, Anouar, Hermanides, Renicus S., Meuwissen, Martijn, Protopopov, Alexey V., Laanmets, Peep, Krestyaninov, Oleg V., Dennert, Robert, Oemrawsingh, Rohit M., van Kuijk, Jan-Peter, Arkenbout, Karin, van der Heijden, Dirk J., Rasoul, Saman, Lipsic, Erik, Rodwell, Laura, Camaro, Cyril, Damman, Peter, Roleder, Tomasz, Kedhi, Elvin, van Leeuwen, Maarten A.H., van Geuns, Robert-Jan M., and van Royen, Niels

Published
2024
Full Text
View/download PDF

6. Drug-coated balloon angioplasty with rescue stenting versus intended stenting for the treatment of patients with de novo coronary artery lesions (REC-CAGEFREE I): an open-label, randomised, non-inferiority trial

Author

Gao, Chao, He, Xingqiang, Ouyang, Fan, Zhang, Zhihui, Shen, Guidong, Wu, Mingxing, Yang, Ping, Ma, Likun, Yang, Feng, Ji, Zheng, Wang, Hua, Wu, Yanqing, Fang, Zhenfei, Jiang, Hong, Wen, Shangyu, Liu, Yi, Li, Fei, Zhou, Jingyu, Zhu, Bin, Liu, Yunpeng, Zhang, Ruining, Zhang, Tingting, Wang, Ping, Liu, Jianzheng, Jiang, Zhiwei, Xia, Jielai, van Geuns, Robert-Jan, Capodanno, Davide, Garg, Scot, Onuma, Yoshinobu, Wang, Duolao, Serruys, Patrick W, and Tao, Ling

Published
2024
Full Text
View/download PDF

7. Impact of repeat revascularization within 5 years on 10-year mortality after percutaneous or surgical revascularization

Author

Wang, Rutao, Lunardi, Mattia, Hara, Hironori, Gao, Chao, Ono, Masafumi, Davierwala, Piroze M., Holmes, David R., Mohr, Friedrich W., Curzen, Nick, Burzotta, Francesco, van Geuns, Robert-Jan, Kappetein, Arie Pieter, Head, Stuart J., Thuijs, Daniel J. F. M., Tao, Ling, Garg, Scot, Onuma, Yoshinobu, Wijns, William, and Serruys, Patrick W.

Published
2023
Full Text
View/download PDF

12. Geographic disparity in 10-year mortality after coronary artery revascularization in the SYNTAXES trial

Author

Kageyama, Shigetaka, Serruys, Patrick W., Garg, Scot, Ninomiya, Kai, Masuda, Shinichiro, Kotoku, Nozomi, Colombo, Antonio, Mack, Michael J., Banning, Adrian P., Morice, Marie-Claude, Witkowski, Adam, Curzen, Nick, Burzotta, Francesco, James, Stefan, van Geuns, Robert-Jan, Davierwala, Piroze M., Holmes, David R., Jr, Wood, David A., McEvoy, John William, and Onuma, Yoshinobu

Published
2022
Full Text
View/download PDF

14. Cardiac Rehabilitation versus Percutaneous Coronary Intervention for Stable Angina Pectoris: A Retrospective Study of Effects on Major Adverse Cardiovascular Events and Associated Healthcare Costs

Author

de Koning, Iris A, primary, Heutinck, Joyce M, additional, Vromen, Tom, additional, Bakker, Esmée A, additional, Maessen, Martijn F H, additional, Smolders, Jurgen, additional, Eijsvogels, Thijs M H, additional, Grutters, Janneke P C, additional, van Geuns, Robert-Jan M, additional, Kemps, Hareld M C, additional, and Thijssen, Dick H J, additional

Published
2024
Full Text
View/download PDF

15. Ten-year all-cause death following percutaneous or surgical revascularization in patients with prior cerebrovascular disease: insights from the SYNTAX Extended Survival study

Author

Wang, Rutao, Takahashi, Kuniaki, Garg, Scot, Thuijs, Daniel J. F. M., Kappetein, Arie Pieter, Mack, Michael J., Morice, Marie-Claude, Mohr, Friedrich-Wilhelm, Curzen, Nick, Davierwala, Piroze, Milojevic, Milan, van Geuns, Robert Jan, Head, Stuart J., Onuma, Yoshinobu, Holmes, Jr, David R., and Serruys, Patrick W.

Published
2021
Full Text
View/download PDF

17. Effects of the PCSK9 antibody alirocumab on coronary atherosclerosis in patients with acute myocardial infarction: a serial, multivessel, intravascular ultrasound, near-infrared spectroscopy and optical coherence tomography imaging study–Rationale and design of the PACMAN-AMI trial

Author

Zanchin, Christian, Koskinas, Konstantinos C., Ueki, Yasushi, Losdat, Sylvain, Häner, Jonas D., Bär, Sarah, Otsuka, Tatsuhiko, Inderkum, Andrea, Jensen, Maria Radu Juul, Lonborg, Jacob, Fahrni, Gregor, Ondracek, Anna S., Daemen, Joost, van Geuns, Robert-Jan, Iglesias, Juan F., Matter, Christian M., Spirk, David, Juni, Peter, Mach, Francois, Heg, Dik, Engstrom, Thomas, Lang, Irene, Windecker, Stephan, and Räber, Lorenz

Published
2021
Full Text
View/download PDF

18. Lesion-Level Effects of LDL-C–Lowering Therapy in Patients With Acute Myocardial Infarction: A Post Hoc Analysis of the PACMAN-AMI Trial

Author

Biccirè, Flavio G., Kakizaki, Ryota, Koskinas, Konstantinos C., Ueki, Yasushi, Häner, Jonas, Shibutani, Hiroki, Lønborg, Jacob, Spitzer, Ernest, Iglesias, Juan F., Otsuka, Tatsuhiko, Siontis, George C. M., Stortecky, Stefan, Kaiser, Christoph, Ambühl, Maria, Morf, Laura, Ondracek, Anna S., van Geuns, Robert-Jan, Spirk, David, Daemen, Joost, Mach, François, Windecker, Stephan, Engstrøm, Thomas, Lang, Irene, Losdat, Sylvain, and Räber, Lorenz

Abstract

IMPORTANCE: Previous studies investigated atherosclerotic changes induced by lipid-lowering therapy in extensive coronary segments irrespective of baseline disease burden (a vessel-level approach). OBJECTIVE: To investigate the effects of lipid-lowering therapy on coronary lesions with advanced atherosclerotic plaque features and presumably higher risk for future events. DESIGN, SETTING, AND PARTICIPANTS: The PACMAN-AMI randomized clinical trial (enrollment: May 2017 to October 2020; final follow-up: October 2021) randomized patients with acute myocardial infarction to receive alirocumab or placebo in addition to high-intensity statin therapy. In this post hoc lesion-level analysis, nonculprit lesions were identified as segments with plaque burden 40% or greater defined by intravascular ultrasound (IVUS). IVUS, near-infrared spectroscopy, and optical coherence tomography images at baseline and the 52-week follow-up were manually matched by readers blinded to treatment allocation. Data for this study were analyzed from October 2022 to November 2023. INTERVENTIONS: Alirocumab or placebo in addition to high-intensity statin therapy. MAIN OUTCOMES AND MEASURES: Lesion-level imaging outcome measures, including high-risk plaque characteristics and phenotypes. RESULTS: Of the 245 patients in whom lesions were found, 118 were in the alirocumab group (mean [SD] age, 58.2 [10.0] years; 101 [85.6%] male and 17 [14.4%] female) and 127 in the placebo group (mean [SD] age, 57.7 [8.8] years; 104 [81.9%] male and 23 [18.1%] female). Overall, 591 lesions were included: 287 lesions (118 patients, 214 vessels) in the alirocumab group and 304 lesions (127 patients, 239 vessels) in the placebo group. Lesion-level mean change in percent atheroma volume (PAV) was −4.86% with alirocumab vs −2.78% with placebo (difference, −2.02; 95% CI, −3.00 to −1.05; P < .001). At the minimum lumen area (MLA) site, mean change in PAV was −10.14% with alirocumab vs −6.70% with placebo (difference, −3.36; 95% CI, −4.98 to −1.75; P < .001). MLA increased by 0.15 mm2 with alirocumab and decreased by 0.07 mm2 with placebo (difference, 0.21; 95% CI, 0.01 to 0.41; P = .04). Among 122 lipid-rich lesions, 34 of 55 (61.8%) in the alirocumab arm and 27 of 67 (41.8%) in the placebo arm showed a less lipid-rich plaque phenotype at follow-up (P = .03). Among 63 lesions with thin-cap fibroatheroma at baseline, 8 of 26 (30.8%) in the alirocumab arm and 3 of 37 (8.1%) in the placebo arm showed a fibrous/fibrocalcific plaque phenotype at follow-up (P = .02). CONCLUSIONS AND RELEVANCE: At the lesion level, very intensive lipid-lowering therapy induced substantially greater PAV regression than described in previous vessel-level analyses. Compared with statin therapy alone, alirocumab treatment was associated with greater enlargement of the lesion MLA and more frequent transition of presumably high-risk plaque phenotypes into more stable, less lipid-rich plaque phenotypes. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03067844

Published
2024
Full Text
View/download PDF

19. Impact of chronic obstructive pulmonary disease on 10-year mortality after percutaneous coronary intervention and bypass surgery for complex coronary artery disease: insights from the SYNTAX Extended Survival study

Author

Wang, Rutao, Tomaniak, Mariusz, Takahashi, Kuniaki, Gao, Chao, Kawashima, Hideyuki, Hara, Hironori, Ono, Masafumi, van Klaveren, David, van Geuns, Robert-Jan, Morice, Marie-Claude, Davierwala, Piroze M., Mack, Michael J., Witkowski, Adam, Curzen, Nick, Berti, Sergio, Burzotta, Francesco, James, Stefan, Kappetein, Arie Pieter, Head, Stuart J., Thuijs, Daniel J. F. M., Mohr, Friedrich W., Holmes, David R., Tao, Ling, Onuma, Yoshinobu, and Serruys, Patrick W.

Published
2021
Full Text
View/download PDF

20. Regional variation in patients and outcomes in the GLOBAL LEADERS trial

Author

Gao, Chao, Takahashi, Kuniaki, Garg, Scot, Hara, Hironori, Wang, Rutao, Kawashima, Hideyuki, Ono, Masafumi, Montalescot, Gilles, Haude, Michael, Slagboom, Ton, Vranckx, Pascal, Valgimigli, Marco, Windecker, Stephan, Hamm, Christian, Steg, Philippe Gabriel, Storey, Robert, van Geuns, Robert-Jan, Tao, Ling, Onuma, Yoshinobu, and Serruys, Patrick W.

Published
2021
Full Text
View/download PDF

22. Impact of symptom duration and mechanical circulatory support on prognosis in cardiogenic shock complicating acute myocardial infarction

Author

Team Medisch, Circulatory Health, Klein, Florien, Crooijmans, Caïa, Peters, Elma J, van 't Veer, Marcel, Timmermans, Marijke J C, Henriques, José P S, Verouden, Niels J W, Kraaijeveld, Adriaan O, Bunge, Jeroen J H, Lipsic, Erik, Sjauw, Krischan D, van Geuns, Robert-Jan M, Dedic, Admir, Dubois, Eric A, Meuwissen, Martijn, Danse, Peter, Bleeker, Gabe, Montero-Cabezas, José M, Ferreira, Irlando A, Brouwer, Jan, Teeuwen, Koen, Otterspoor, Luuk C, PCI registration committee of the Netherlands Heart Registration, Team Medisch, Circulatory Health, Klein, Florien, Crooijmans, Caïa, Peters, Elma J, van 't Veer, Marcel, Timmermans, Marijke J C, Henriques, José P S, Verouden, Niels J W, Kraaijeveld, Adriaan O, Bunge, Jeroen J H, Lipsic, Erik, Sjauw, Krischan D, van Geuns, Robert-Jan M, Dedic, Admir, Dubois, Eric A, Meuwissen, Martijn, Danse, Peter, Bleeker, Gabe, Montero-Cabezas, José M, Ferreira, Irlando A, Brouwer, Jan, Teeuwen, Koen, Otterspoor, Luuk C, and PCI registration committee of the Netherlands Heart Registration

Published
2024

24. Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

Author

Abdellaoui, Mohamed, Adlam, David, Akin, Ibrahim, Albarran Gonzalez-Trevilla, Agustin, Almeida, Manuel, Alves Lemos Neto, Pedro, Aminian, Adel, Anderson, Richard, Andreae, Rick, Angioi, Michael, Asano, Taku, Barbato, Emanuele, Barlis, Peter, Barraud, Pascal, Benit, Edouard, Bertrand, Olivier, Beygui, Farzin, Bolognese, Leonardo, Botelho, Roberto, Bouwman, Coby, Bressers, Marco, Brunel, Philippe, Buszman, Pawel, Buysschaert, Ian, Canas da Silva, Pedro, Carrie, Didier, Cequier, Angel, Chichareon, Ply, Chin Chang, Chun, Chowdhary, Saqib, Collet, Carlos, Colombo, Antonio, Cotton, James, Cruz Ferreira, Rui, Curello, Salvatore, Curzen, Nick, de Bot, Judith, de Vreede, Tone, Delle Karth, Georg, Dijksma, Lynn, Dominici, Marcello, Édes, István, Eeckhout, Eric, Eitel, Ingo, Faluközy, József, Fath-Ordoubadi, Farzin, Ferrario, Maurizio, Fontos, Geza, Francisco Diaz, Jose, Freitas Quintella, Edgard, Frey, Bernhard, Friedrich, Guy, Galasko, Gavin, Galuszka, Grzegorz, Gama Ribeiro, Vasco, Garg, Scot, Gargiulo, Giuseppe, Geisler, Tobias, Gelev, Valeri, Ghandilyan, Art, Goicolea, Javier, Gori, Tommaso, Gragnano, Felice, Guimarães, Ana, Hamm, Christian, Haude, Michael, Heg, Dik, Heijke, Pieter, Hernández Antolin, Rosa Ana, Hildick-Smith, David, Hillen, Dorien, Hoekman, Ina, Hofma, Sjoerd, Holmvang, Lene, Hoole, Stephen, Horváth, Iván, Huber, Kurt, Hugense, Annemarie, Ibrahim, Karim, Iñiguez, Andres, Isaaz, Karl, Jambrik, Zoltán, Janssens, Luc, Jasionowicz, Pawel, Jonk, Judith, Jung, Werner, Jüni, Peter, Katagiri, Yuki, Kogame, Norihiro, Koh, Tian Hai, Koning, René, Konteva, Mariana, Kőszegi, Zsolt, Krackhardt, Florian, Kreuger, Yvonne, Kukreja, Neville, Ladan, Boudijn, Lantelme, Pierre, Leandro, Sergio, Leibundgut, Gregor, Liebetrau, Christoph, Lindeboom, Wietze, Macaya Miguel, Carlos, Mach, François, Magro, Michael, Maillard, Luc, Manavifar, Negar, Mauri, Laura, McFadden, Eugene, Merkely, Bela, Miyazaki, Yosuke, Młodziankowski, Adam, Moccetti, Tiziano, Modolo, Rodrigo, Möllman, Helge, Morelle, Jean-François, Moschovitis, Aris, Munndt Ottesen, Michael, Muurling, Martin, Naber, Christoph Kurt, Neumann, Franz-Josef, Oldroyd, Keith, Ong, Paul, Onuma, Yoshinobu, Palsrok, Sanne, Petrov, Ivo, Plante, Sylvain, Prokopczuk, Janusz, Rademaker-Havinga, Tessa, Raffel, Christopher, Rensing, Benno, Roffi, Marco, Royaards, Kees-Jan, Sabate, Manel, Schächinger, Volker, Seidler, Tim, Serra Peñaranda, Antonio, Serruys, Patrick, Sikarulidze, Lali, Slagboom, Ton, Soliman, Osama I, Sousa, Amanda, Spitzer, Ernest, Stables, Rod, Steg, Gabriel, Steinwender, Clemens, Subkovas, Eduardas, Suryapranata, Harry, Takahashi, Kuniaki, Talwar, Suneel, Teiger, Emmanuel, ter Weele, Addy, Teurlings, Eva, Thury, Attila, Tijssen, Jan, Tonev, Gincho, Trendafilova-Lazarova, Diana, Tumscitz, Carlo, Umans, Victor, Ungi, Imre, Valkov, Veselin, van der Harst, Pim, van Geuns, Robert Jan, van Meijeren, Cokky, Vassilev, Dobrin, Velchev, Vasil, Velthuizen, Esther, Verheugt, Freek, Vlcek, Natalia, vom Dahl, Jürgen, Vrolix, Mathias, Walsh, Simon, Werner, Nikos, Windecker, Stephan, Witsenburg, Maarten, Zaman, Azfar, Żmudka, Krzysztof, Zrenner, Bernhard, Zurakowski, Aleksander, Zweiker, Robert, Vranckx, Pascal, Valgimigli, Marco, Steg, Philippe Gabriel, van Es, Gerrit Anne, McFadden, Eugene P, Möllmann, Helge, Van Geuns, Robert Jan, and Serruys, Patrick W

Published
2018
Full Text
View/download PDF

25. The impact of pre-procedure heart rate on adverse clinical outcomes in patients undergoing percutaneous coronary intervention: Results from a 2-year follow-up of the GLOBAL LEADERS trial

Author

Wang, Rutao, Takahashi, Kuniaki, Chichareon, Ply, Gao, Chao, Kogame, Norihiro, Modolo, Rodrigo, Tomaniak, Mariusz, Kawashima, Hideyuki, Ono, Masafumi, Hara, Hironori, Schächinger, Volker, Tonev, Gincho, Ungi, Imre, Botelho, Roberto, Eeckhout, Eric, Hamm, Christian, Jüni, Peter, Vranckx, Pascal, Windecker, Stephan, Garg, Scot, Van Geuns, Robert Jan, Onuma, Yoshinobu, and Serruys, Patrick W.

Published
2020
Full Text
View/download PDF

26. Intravascular Polarimetry in Patients With Coronary Artery Disease

Author

Otsuka, Kenichiro, Villiger, Martin, Karanasos, Antonios, van Zandvoort, Laurens J.C., Doradla, Pallavi, Ren, Jian, Lippok, Norman, Daemen, Joost, Diletti, Roberto, van Geuns, Robert-Jan, Zijlstra, Felix, van Soest, Gijs, Dijkstra, Jouke, Nadkarni, Seemantini K., Regar, Evelyn, and Bouma, Brett E.

Published
2020
Full Text
View/download PDF

27. Invasive coronary imaging of inflammation to further characterize high-risk lesions: what options do we have?

Author

Los, Jonathan, primary, Mensink, Frans B., additional, Mohammadnia, Niekbachsh, additional, Opstal, Tjerk S. J., additional, Damman, Peter, additional, Volleberg, Rick H. J. A., additional, Peeters, Denise A. M., additional, van Royen, Niels, additional, Garcia-Garcia, Hector M., additional, Cornel, Jan H., additional, El Messaoudi, Saloua, additional, and van Geuns, Robert-Jan M., additional

Published
2024
Full Text
View/download PDF

28. Using Upper Arm Vein as Temporary Pacemaker Access Site: A Next Step in Minimizing the Invasiveness of Transcatheter Aortic Valve Replacement

Author

Rooijakkers, Maxim J. P., primary, Versteeg, Geert A. A., additional, van Wely, Marleen H., additional, Rodwell, Laura, additional, van Nunen, Lokien X., additional, van Geuns, Robert Jan, additional, van Garsse, Leen A. F. M., additional, Geuzebroek, Guillaume S. C., additional, Verkroost, Michel W. A., additional, Heijmen, Robin H., additional, and van Royen, Niels, additional

Published
2024
Full Text
View/download PDF

29. Pre-hospital rule-out of non-ST-segment elevation acute coronary syndrome by a single troponin: final one-year outcomes of the ARTICA randomised trial

Author

Aarts, Goaris W A, primary, Camaro, Cyril, additional, Adang, Eddy M M, additional, Rodwell, Laura, additional, van Hout, Roger, additional, Brok, Gijs, additional, Hoare, Anouk, additional, de Pooter, Frank, additional, de Wit, Walter, additional, Cramer, Gilbert E, additional, van Kimmenade, Roland R J, additional, Ouwendijk, Eva, additional, Rutten, Martijn H, additional, Zegers, Erwin, additional, van Geuns, Robert-Jan M, additional, Gomes, Marc E R, additional, Damman, Peter, additional, and van Royen, Niels, additional

Published
2024
Full Text
View/download PDF

30. Impact of recruitment and retention on all-cause mortality in a large all-comers randomised controlled trial: insights from the GLOBAL LEADERS trial

Author

Takahashi, Kuniaki, Kogame, Norihiro, Tomaniak, Mariusz, Chichareon, Ply, Chang, Chun-Chin, Modolo, Rodrigo, Benit, Edouard, Liebetrau, Christoph, Janssens, Luc, Ferrario, Maurizio, Zurakowski, Aleksander, van Geuns, Robert Jan, Dominici, Marcello, Huber, Kurt, Buszman, Pawel, Bolognese, Leonardo, Tumscitz, Carlo, Żmudka, Krzysztof, Aminian, Adel, Vrolix, Mathias, Petrov, Ivo, Wykrzykowska, Joanna J., de Winter, Robbert J., Hamm, Christian, Steg, Philippe Gabriel, Onuma, Yoshinobu, Valgimigli, Marco, Windecker, Stephan, Vranckx, Pascal, Garg, Scot, and Serruys, Patrick W.

Published
2020
Full Text
View/download PDF

31. Ascertainment of Silent Myocardial Infarction in Patients Undergoing Percutaneous Coronary Intervention (from the GLOBAL LEADERS Trial)

Author

Chang, Chun Chin, Spitzer, Ernest, Chichareon, Ply, Takahashi, Kuniaki, Modolo, Rodrigo, Kogame, Norihiro, Tomaniak, Mariusz, Komiyama, Hidenori, Yap, Sing-Chien, Hoole, Stephen P., Gori, Tommaso, Zaman, Azfar, Frey, Bernhard, Ferreira, Rui Cruz, Bertrand, Olivier F., Koh, Tian Hai, Sousa, Amanda, Moschovitis, Aris, van Geuns, Robert-Jan, Steg, Philippe Gabriel, Hamm, Christian, Jüni, Peter, Vranckx, Pascal, Valgimigli, Marco, Windecker, Stephan, Serruys, Patrick W., Soliman, Osama, and Onuma, Yoshinobu

Published
2019
Full Text
View/download PDF

32. Clinical Implication of Quantitative Flow Ratio After Percutaneous Coronary Intervention for 3-Vessel Disease

Author

Kogame, Norihiro, Takahashi, Kuniaki, Tomaniak, Mariusz, Chichareon, Ply, Modolo, Rodrigo, Chang, Chun Chin, Komiyama, Hidenori, Katagiri, Yuki, Asano, Taku, Stables, Rod, Fath-Ordoubadi, Farzin, Walsh, Simon, Sabaté, Manel, Davies, Justin E., Piek, Jan.J., van Geuns, Robert-Jan, Reiber, Johan H.C., Banning, Adrian P., Escaned, Javier, Farooq, Vasim, Serruys, Patrick W., and Onuma, Yoshinobu

Published
2019
Full Text
View/download PDF

33. Absorb Bioresorbable Scaffold Versus Xience Metallic Stent for Prevention of Restenosis Following Percutaneous Coronary Intervention in Patients at High Risk of Restenosis: Rationale and Design of the COMPARE ABSORB Trial

Author

Chang, Chun Chin, Onuma, Yoshinobu, Achenbach, Stephan, Barbato, Emanuele, Chevalier, Bernard, Cook, Stéphane, Dudek, Dariusz, Escaned, Javier, Gori, Tommaso, Kočka, Viktor, Tarantini, Giuseppe, West, Nick E.J., Morice, Marie-Claude, Tijssen, Jan G.P., van Geuns, Robert-Jan, and Smits, Pieter C.

Published
2019
Full Text
View/download PDF

34. Fractional Flow Reserve–Negative High-Risk Plaques and Clinical Outcomes After Myocardial Infarction

Author

Mol, Jan-Quinten, primary, Volleberg, Rick H. J. A., additional, Belkacemi, Anouar, additional, Hermanides, Renicus S., additional, Meuwissen, Martijn, additional, Protopopov, Alexey V., additional, Laanmets, Peep, additional, Krestyaninov, Oleg V., additional, Dennert, Robert, additional, Oemrawsingh, Rohit M., additional, van Kuijk, Jan-Peter, additional, Arkenbout, Karin, additional, van der Heijden, Dirk J., additional, Rasoul, Saman, additional, Lipsic, Erik, additional, Rodwell, Laura, additional, Camaro, Cyril, additional, Damman, Peter, additional, Roleder, Tomasz, additional, Kedhi, Elvin, additional, van Leeuwen, Maarten A. H., additional, van Geuns, Robert-Jan M., additional, and van Royen, Niels, additional

Published
2023
Full Text
View/download PDF

35. Differences in risk and costs between prehospital identified low-risk men and women with chest pain

Author

Aarts, Goaris W A, primary, Camaro, Cyril, additional, Rodwell, Laura, additional, Adang, Eddy M M, additional, van Hout, Roger, additional, Brok, Gijs, additional, Hoare, Anouk, additional, de Pooter, Frank P C, additional, de Wit, Walter, additional, Cramer, Gilbert E, additional, van Kimmenade, Roland R J, additional, Ouwendijk, Eva, additional, Rutten, Martijn, additional, Zegers, Erwin, additional, van Geuns, Robert-Jan M, additional, Gomes, Marc E R, additional, Damman, Peter, additional, and van Royen, Niels, additional

Published
2023
Full Text
View/download PDF

37. TCT-479 A Propensity-Matched Analysis of Mechanical Circulatory Support in Cardiogenic Shock Complicating Acute Myocardial Infarction: Insights From the Netherlands

Author

Bogerd, Margriet, primary, Peters, Elma, additional, Berg, Sanne ten, additional, Timmermans, Marijke, additional, Engström, Annemarie, additional, Otterspoor, Luuk, additional, Bunge, Jeroen, additional, Griffioen, Alexander, additional, Van Geuns, Robert-Jan, additional, Vlaar, Alexander, additional, and Henriques, Jose, additional

Published
2023
Full Text
View/download PDF

42. On-Pump and Off-Pump Coronary Artery Bypass Grafting on 10-Year Mortality Versus Percutaneous Coronary Intervention

Author

Serruys, Patrick W., primary, Kageyama, Shigetaka, additional, Ninomiya, Kai, additional, O'Leary, Neil, additional, Masuda, Shinichiro, additional, Kotoku, Nozomi, additional, Colombo, Antonio, additional, van Geuns, Robert-Jan, additional, Milojevic, Milan, additional, Mack, Michael J., additional, Soo, Alan, additional, Garg, Scot, additional, and Onuma, Yoshinobu, additional

Published
2023
Full Text
View/download PDF

44. Serial Assessment of Tissue Precursors and Progression of Coronary Calcification Analyzed by Fusion of IVUS and OCT: 5-Year Follow-Up of Scaffolded and Nonscaffolded Arteries

Author

Zeng, Yaping, Tateishi, Hiroki, Cavalcante, Rafael, Tenekecioglu, Erhan, Suwannasom, Pannipa, Sotomi, Yohei, Collet, Carlos, Nie, Shaoping, Jonker, Hans, Dijkstra, Jouke, Radu, Maria D., Räber, Lorenz, McClean, Dougal R., van Geuns, Robert-Jan, Christiansen, Evald H., Fahrni, Therese, Koolen, Jacques, Onuma, Yoshinobu, Bruining, Nico, and Serruys, Patrick W.

Published
2017
Full Text
View/download PDF

47. Reduced duration of dual antiplatelet therapy using an improved drug-eluting stent for percutaneous coronary intervention of the left main artery in a real-world, all-comer population: Rationale and study design of the prospective randomized multicenter IDEAL-LM trial

Author

Lemmert, Miguel E., Oldroyd, Keith, Barragan, Paul, Lesiak, Maciej, Byrne, Robert A., Merkulov, Evgeny, Daemen, Joost, Onuma, Yoshinobu, Witberg, Karen, and van Geuns, Robert-Jan

Published
2017
Full Text
View/download PDF

49. Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trial

Author

Gao, Chao, Tomaniak, Mariusz, Takahashi, Kuniaki, Kawashima, Hideyuki, Wang, Rutao, Hara, Hironori, Ono, Masafumi, Montalescot, Gilles, Garg, Scot, Haude, Michael, Slagboom, Ton, Vranckx, Pascal, Valgimigli, Marco, Windecker, Stephan, van Geuns, Robert-Jan, Hamm, Christian, Steg, Philippe Gabriel, Onuma, Yoshinobu, Angiolillo, Dominick J., and Serruys, Patrick W.

Published
2020
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results